Allergy medication for bee stings ranges from over-the-counter antihistamines for mild localised reactions to prescribed adrenaline auto-injectors and specialist venom immunotherapy for those at risk of anaphylaxis. Understanding which treatment is appropriate — and when to call 999 — can be life-saving. This article explains how the body reacts to bee venom, which medications are available on the NHS and over the counter, when to seek emergency care, and how long-term management through venom immunotherapy can significantly reduce the risk of future severe reactions.

How the Body Reacts to Bee Stings

When a bee stings, it injects venom through its stinger into the skin. This venom contains a complex mixture of proteins and enzymes — including melittin, phospholipase A2, and hyaluronidase — that trigger an immune response. For most people, this results in a localised reaction: immediate pain, redness, swelling, and itching around the sting site, which typically resolves within a few hours to a couple of days.

Immediate first aid for any bee sting includes:

• Removing the stinger promptly by scraping it sideways with a fingernail, bank card, or blunt edge — do not squeeze or use tweezers, as this may release more venom

• Washing the area with soap and water

• Applying a cold compress or ice pack (wrapped in a cloth) to reduce swelling

• Taking paracetamol or ibuprofen (if suitable) for pain relief

Some individuals develop a large localised reaction, where swelling extends significantly beyond the sting site and may persist for several days. This is uncomfortable but is not considered a systemic allergic reaction. The risk of a future systemic reaction in people who have only ever had large localised reactions is low — estimated at around 5–10% — and does not automatically indicate a high risk of anaphylaxis (BSACI Hymenoptera venom allergy guideline).

In a smaller proportion of people — estimated at approximately 1–3% of adults in the UK (BSACI) — the immune system mounts a systemic (whole-body) allergic response. This occurs when the immune system has previously been sensitised to bee venom and produces immunoglobulin E (IgE) antibodies. On re-exposure, these antibodies trigger mast cells and basophils to release histamine and other inflammatory mediators throughout the body. This cascade can lead to symptoms ranging from widespread urticaria (hives) and angioedema to life-threatening anaphylaxis, which may involve:

• Respiratory difficulty (wheeze, throat tightening, stridor)

• Cardiovascular collapse (drop in blood pressure, rapid or weak pulse)

• Gastrointestinal symptoms (nausea, vomiting)

• Loss of consciousness

It is also worth noting that multiple bee stings can cause non-allergic systemic toxicity — even in people without a venom allergy — due to the sheer volume of venom injected. This also requires urgent medical review.

Understanding the distinction between a normal localised reaction and a systemic allergic response is essential for choosing the appropriate allergy medication for bee stings and knowing when urgent medical attention is required.

Allergy Medications Used to Treat Bee Sting Reactions

The choice of allergy medication for bee stings depends on the severity of the reaction. For mild to moderate localised reactions, over-the-counter treatments are usually sufficient and can be obtained from a pharmacy without a prescription.

Antihistamines are the most commonly used first-line medications for managing localised allergic symptoms. They work by blocking histamine H1 receptors, thereby reducing itching, redness, and swelling. Non-sedating antihistamines — such as cetirizine, loratadine, or fexofenadine — are generally preferred during the day, as they are less likely to cause drowsiness. Always follow the dosage instructions on the pack or patient information leaflet, and seek advice from a pharmacist regarding suitability — particularly for children, older adults, those who are pregnant or breastfeeding, or those with other medical conditions or taking other medicines. A pharmacist or GP can advise on the most appropriate product and dose for your circumstances (BNF; emc SmPCs).

Sedating antihistamines such as chlorphenamine (Piriton) may be appropriate in some circumstances but should be used with caution. They can impair the ability to drive or operate machinery, and alcohol can increase drowsiness. They should be used with particular care in older adults.

Topical antihistamine or local anaesthetic creams are not recommended for bee sting reactions, as they carry a risk of causing contact sensitisation (NICE CKS: Insect bites and stings).

Topical treatments that may help relieve localised discomfort include:

• Hydrocortisone 1% cream (available over the counter) to reduce localised inflammation — follow pack instructions and do not apply to broken skin

• Calamine lotion to soothe itching

• Cold compress or ice pack (wrapped in a cloth) applied to the sting site

For large localised reactions, a short course of oral corticosteroids (such as prednisolone) may occasionally be prescribed by a GP to reduce significant swelling and inflammation, though this is not routinely required. This requires prescriber assessment and oversight; do not self-medicate with corticosteroids (NICE CKS: Insect bites and stings; BNF).

It is important to note that antihistamines and topical or oral steroids are not appropriate treatments for anaphylaxis. They may be used as adjuncts after initial emergency treatment, but they do not act quickly enough to reverse the life-threatening features of a severe allergic reaction. Patients with a known severe bee venom allergy should always carry their prescribed emergency medication and be aware of its correct use.

If you experience any suspected side effects from medicines used to treat a bee sting reaction, you can report these to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

When to Seek Emergency Treatment for a Bee Sting

Recognising the warning signs of a severe allergic reaction is potentially life-saving. Anaphylaxis is a medical emergency and requires immediate treatment with intramuscular adrenaline (epinephrine), followed by an immediate call to 999 for emergency services. Waiting to see whether symptoms resolve on their own is not appropriate when systemic features are present.

The NHS and the Resuscitation Council UK (RCUK) advise that anaphylaxis should be suspected when a bee sting is followed by any of the following:

• Throat tightening, hoarseness, or difficulty swallowing

• Wheezing, shortness of breath, or stridor

• Widespread urticaria (hives) or flushing beyond the sting site

• Dizziness, fainting, or collapse

• Rapid or weak pulse

• Pale or clammy skin

• Nausea, vomiting, or abdominal cramps

• Sudden anxiety or a sense of impending doom

For individuals who have been prescribed an adrenaline auto-injector (AAI) — such as an EpiPen, Jext, or Emerade — this should be administered into the outer thigh at the first sign of anaphylaxis. It can be given through clothing. Call 999 immediately after administering the first dose. A second dose may be given after 5 minutes if symptoms do not improve and a second device is available. The person should then:

• Lie flat with their legs raised if they feel faint or have collapsed

• Sit up if they are having difficulty breathing

• Not stand or walk

• If in late pregnancy, lie on their left side

Emergency services must be called regardless of apparent improvement after adrenaline, as symptoms can return.

Following emergency treatment, hospital observation is recommended in line with RCUK 2021 risk-stratified guidance: at least 2 hours after resolution of symptoms for those at lower risk; at least 6 hours for most patients; and at least 12 hours for those with severe features, a previous biphasic reaction, or other high-risk factors. A biphasic reaction — a second wave of anaphylaxis occurring hours after the initial episode — is a recognised risk and is one reason why observation in hospital is essential even if the person feels well after treatment (Resuscitation Council UK: Emergency treatment of anaphylaxis, 2021).

Anyone who has experienced a systemic reaction to a bee sting should be referred to an allergy specialist for further assessment.

Prescribed Treatments and Venom Immunotherapy on the NHS

For individuals with a confirmed bee venom allergy, particularly those who have experienced anaphylaxis, NHS treatment extends beyond acute management to include longer-term preventive strategies.

Adrenaline auto-injectors (AAIs) are prescribed to patients at risk of anaphylaxis. The MHRA Drug Safety Update advises that two AAIs should be prescribed and carried at all times, and that patients and their carers receive training on correct administration technique. Devices should be checked regularly for expiry dates. AAIs currently available on the NHS include:

• EpiPen (0.15 mg for children 15–30 kg; 0.3 mg for adults and children over 30 kg)

• Jext (0.15 mg for children 15–30 kg; 0.3 mg for adults and children over 30 kg)

• Emerade (0.15 mg, 0.3 mg, and 0.5 mg — the 0.5 mg strength may be considered for adults over approximately 60 kg, as directed by a specialist)

The appropriate device and strength should be selected based on the patient's weight and clinical assessment, in discussion with their prescriber (MHRA Drug Safety Update on adrenaline auto-injectors; emc SmPCs for EpiPen, Jext, and Emerade; NICE CG134).

Venom immunotherapy (VIT), also known as desensitisation, is the only disease-modifying treatment available for bee venom allergy. It involves the administration of gradually increasing doses of purified bee venom extract over a period of months, followed by maintenance doses, typically for three to five years. The aim is to reprogram the immune system so that it no longer mounts a dangerous response to bee venom.

According to NICE guidance (TA246) and the British Society for Allergy and Clinical Immunology (BSACI), VIT is recommended for adults and selected children and young people who have experienced a systemic allergic reaction to bee or wasp venom and have confirmed IgE-mediated sensitisation. It is highly effective: studies indicate it reduces the risk of a future systemic reaction to approximately 5% or less, with protection rates of around 80–90% for bee venom and approximately 90–95% for wasp venom (NICE TA246; BSACI Hymenoptera venom allergy guideline). VIT is delivered in specialist NHS allergy centres and is not available over the counter or through general practice. Referral is typically made by a GP following a confirmed anaphylactic episode.

As part of specialist assessment, clinicians may also measure acute and baseline serum tryptase and evaluate for underlying clonal mast cell disease (such as mastocytosis), which can increase the risk and severity of venom-triggered anaphylaxis (BSACI guideline).

Managing Bee Sting Allergies: Advice from NHS and NICE

Effective long-term management of a bee sting allergy involves a combination of avoidance strategies, patient education, and access to appropriate emergency medication. The NHS and NICE emphasise that individuals with a known venom allergy should be empowered to manage their condition confidently and safely.

Practical avoidance measures recommended by the NHS include:

• Wearing shoes outdoors, particularly on grass

• Avoiding brightly coloured or floral clothing that may attract bees

• Not using strongly scented perfumes or cosmetics when outdoors

• Keeping food and drinks covered during outdoor activities

• Remaining calm and still if a bee is nearby — sudden movements can provoke stinging

• Avoiding areas with high bee activity, such as orchards or flowering gardens during peak season

If stung, remember to remove the stinger promptly by scraping it sideways, wash the area, and apply a cold compress — as described in the first section above.

Patients should ensure that all relevant people in their environment — including family members, colleagues, and school staff — are aware of their allergy and know how to use an AAI in an emergency. It is strongly advisable to keep a written, personalised emergency action plan and to practise using a trainer device regularly so that administration becomes second nature. Patients should also consider wearing medical alert jewellery or carrying a medical alert card to inform others of their allergy in an emergency. The NHS provides patient information and signposts to organisations such as Allergy UK for additional support.

Following any systemic reaction, GP referral to a specialist allergy clinic is strongly advised. An allergist can confirm the diagnosis through skin prick testing or specific IgE blood tests, measure baseline serum tryptase, assess the risk of future reactions, and determine eligibility for venom immunotherapy (NICE CG134; BSACI guideline).

Finally, patients should be reminded to replace expired AAIs promptly, ensure they always carry two devices, and attend regular reviews with their GP or allergy team. With the right allergy medication for bee stings, appropriate emergency planning, and access to specialist care, most people with bee venom allergy can lead full and active lives with confidence.

If you experience any suspected side effects from medicines used to manage your bee sting allergy, please report them to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Frequently Asked Questions